SOLARA ACTIVE PHARMA [SOLARAPP1] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: SOLARA ACTIVE PHARMA SCIENCES wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. SOLARA ACTIVE PHARMA SCIENCES appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric SOLARA ACTIVE PHARMA SCIENCES Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 300.92 -13.65 SOLARA ACTIVE PHARMA SCIENCES
Price-to-Book Ratio 1.05 -13.55 SOLARA ACTIVE PHARMA SCIENCES
Debt-to-Equity Ratio 51.38 -1.21 SOLARA ACTIVE PHARMA SCIENCES
PEG Ratio -1.02 -11.15 SOLARA ACTIVE PHARMA SCIENCES
EV/EBITDA 11.85 -22.27 SOLARA ACTIVE PHARMA SCIENCES
Profit Margin (TTM) -1.52% -53.22% SOLARA ACTIVE PHARMA SCIENCES
Operating Margin (TTM) 3.37% -700.71% SOLARA ACTIVE PHARMA SCIENCES
EBITDA Margin (TTM) 3.37% N/A N/A
Return on Equity 0.05% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 0.02% -102.08% SOLARA ACTIVE PHARMA SCIENCES
Free Cash Flow (TTM) $1.73B $-3.71B SOLARA ACTIVE PHARMA SCIENCES
1-Year Return 13.08% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 1.66 87.98 SOLARA ACTIVE PHARMA SCIENCES
Enterprise Value $19.97B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.59 95.73 SOLARA ACTIVE PHARMA SCIENCES
Gross Profit Margin (TTM) 46.53% -59.53% SOLARA ACTIVE PHARMA SCIENCES
Revenue per Share (TTM) $231 $2 SOLARA ACTIVE PHARMA SCIENCES
Earnings per Share (Diluted) $-4.82 $-8.25 SOLARA ACTIVE PHARMA SCIENCES
Beta (Stock Volatility) 0.84 0.19 Sun Pharma Advanced Research Company Ltd.

SOLARA ACTIVE PHARMA SCIENCES vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SOLARA ACTIVE PHARMA SCIENCES12.87%2.56%2.47%-20.88%-31.50%-20.88%
Sun Pharma Advanced Research Company Ltd.2.14%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SOLARA ACTIVE PHARMA SCIENCES13.08%31.31%31.31%31.31%31.31%31.31%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Sun Pharma Advanced Research Company Ltd.

MetricSOLARAPP1SPARC
Market Information
Market Cap i₹20.78B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2382,401,062
90 Day Avg. Volume i7042,083,443
Last Close₹308.70₹212.97
52 Week Range₹247.95 - ₹511.00₹108.00 - ₹248.75
% from 52W High-39.59%-14.38%
All-Time High₹511.00 (Aug 29, 2025)₹875.00 (Apr 24, 2006)
% from All-Time High-39.59%-75.66%
Growth Metrics
Quarterly Revenue Growth0.16%-0.43%
Quarterly Earnings Growth0.16%-0.43%
Financial Health
Profit Margin (TTM) i-0.02%-0.53%
Operating Margin (TTM) i0.03%-7.01%
Return on Equity (TTM) i0.00%1.58%
Debt to Equity (MRQ) i51.38-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹293.20₹-10.63
Cash per Share (MRQ)₹0.88₹0.03
Operating Cash Flow (TTM) i₹1.70B₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹5.40M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Sun Pharma Advanced Research Company Ltd.

MetricSOLARAPP1 (Apr 08, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i300.92-13.65
Forward P/E iN/A2.60
PEG Ratio i-1.02-11.15
Price to Sales (TTM) i1.6687.98
Price to Book (MRQ) i1.05-13.55
Market Capitalization
Market Capitalization i₹20.78B₹46.75B
Enterprise Value i₹19.97B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.5995.73
Enterprise to EBITDA i11.85-22.27
Risk & Other Metrics
Beta i0.840.19
Book Value per Share (MRQ) i₹293.20₹-10.63

Financial Statements Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSOLARAPP1 (2025)SPARC (2025)
Revenue/Sales i12.41B717.66M
Cost of Goods Sold i6.46B1.10B
COGS % of Revenue i52.0%153.2%
Gross Profit i5.96B-381.94M
Gross Margin i48.0%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i1.11B-3.34B
Operating Margin i9.0%-465.5%
EBITDA i2.05B-3.23B
EBITDA Margin i16.5%-450.0%
Pre-Tax Income i5.40M-3.43B
Pre-Tax Income % of Revenue i0.0%-477.6%
Income Tax i0-2.72M
Income Tax % of Revenue i0.0%-0.4%
Net Income (Profit) i5.40M-3.43B
Profit Margin i0.0%-477.3%

Balance Sheet & Liquidity Metrics

MetricSOLARAPP1 (2025)SPARC (2025)
Cash & Equivalents i39.50M19.64M
Total Current Assets i7.29B261.97M
Total Current Assets % of Revenue i58.7%36.5%
Total Current Liabilities i9.44B3.74B
Total Current Liabilities % of Revenue i76.0%521.5%
Long-Term Debt i1.32B1.07B
Long-Term Debt % of Revenue i10.6%149.0%
Total Shareholders Equity i10.97B-2.17B
Retained Earnings i-3.16B-23.22B
Retained Earnings % of Revenue i-25.4%-3,235.0%
Property, Plant & Equipment i7.96B178.02M

Cash Flow Statement Comparison

MetricSOLARAPP1 (2025)SPARC (2025)
Operating Cash Flow i1.70B-3.48B
Operating Cash Flow % of Revenue i13.7%-485.5%
Capital Expenditures i3.80M-97.45M
Free Cash Flow i1.73B-3.71B
FCF Margin i13.9%-516.4%
Debt Repayment i-1.11B-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSOLARAPP1SPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.00M324.52M
Float Shares i30.10M91.32M
% Held by Insiders i0.00%72.96%
% Held by Institutions i4.45%2.56%
% Held by Public i95.55%24.48%

Dividend Analysis & Yield Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Sun Pharma Advanced Research Company Ltd.

MetricSOLARAPP1SPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A